WebBackground: Carbonic anhydrase (CA) inhibition provides a target for obstructive sleep apnea (OSA) treatment. Methods: This phase II dose guiding trial evaluated safety and efficacy of sulthiame (a CA inhibitor, STM) after four weeks with STM 200 mg, 400 mg or placebo in OSA patients not tolerating positive airway pressure. Polysomnography (2x2), … Web27 May 2024 · Sulthiame (STM) is an antiepileptic drug with a small carbonic anhydrase inhibition effect. Its half-life is about 8.65 h. There are relevant interactions with carbamazepine, phenobarbital, primidone, phenytoin, and clobazam. It has been shown to be effective in benign childhood epilepsy with centrotemporal spikes and West syndrome …
Sulthiame: Could a Sleep Apnea Drug be on the Horizon? Sleep …
WebBackground: Sulthiame is a central carbonic anhydrase inhibitor found to be effective for both partial and generalized seizures. It has been in use in some European countries and in Israel for over 30 years. The aim of the present study was to evaluate the efficacy and tolerability of sulthiame in childhood epilepsy by conducting a multicenter, retrospective … WebSultiame became established as a second-line drug for treatment of partial epilepsy in the 1960s and 1970s and was often used in combination with the established anticonvulsant … how to upgrade bank in dank memer
Sulthiame on Epilepsy - Clinical Trials Registry - ICH GCP
WebWe've now closed our evidence search service. We’ve taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities … WebSulthiame is a potent inhibitor of carbonic anhydrase II, VII, IX, and XII. Sulthiame is an antiepileptic drug that is used widely in some European countries and in Israel. … Web23 Mar 2024 · In the current issue of the Journal, Hedner and colleagues (pp. 1461–1469) present interesting findings from an industry-funded dose-finding phase II trial exploring safety (primary objective) and efficacy of a fourth CAI—sulthiame—for OSA . In brief, 68 adults with moderate/severe OSA who had abandoned CPAP therapy were randomized to … oregon wanting to join idaho